23 July 2014 - Deborah Wilkes
Archived
GlaxoSmithKline's Consumer Healthcare division reported worldwide sales down by 14% to £1.02 billion (US$1.74 billion) in the second quarter of 2014, as supply problems hit several brands including smoking-control products.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.